ADMA — ADMA Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for ADMA Biologics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	51.1	86.5	51.4	103	87.6
Net Total Accounts Receivable
Net Total Receivables	28.6	15.5	27.4	50	158
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	209	270	257	331	467
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	58.2	68.7	63.5	63.3	71.7
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	276	348	329	489	624
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30.4	39.3	49.8	55.5	69.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	135	196	194	140	147
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	141	152	135	349	477
Total Liabilities & Shareholders' Equity	276	348	329	489	624
Total Common Shares Outstanding